St Cross Special Ethics Seminar: Professor Jacqueline Fox

'What to Expect in United States Health Care Reform'

Date: Thursday, 10 June, 5.30 - 7.00 pm
Venue: St Cross Room, St Cross College, Oxford
Abstract: United States healthcare reform promises some substantial changes. Professor Fox will speak about the new healthcare law, as well as some of the major challenges that it faces during its implementation. Some degree of political will is required to sustain the vision of the law, and Fox will highlight the areas that are most vulnerable, particularly regulation of industry and reimbursement cost controls.
Further details: Jacqueline Fox joined the faculty of the University of South Carolina School of Law as an assistant professor in 2005. She currently teaches health law, a seminar on bioethics and torts and has also taught administrative law. Prior to moving to South Carolina, Fox was a Donaghue visiting scholar in research ethics at Yale University. She has also completed a 2-year post-doctoral Greenwall Fellowship in bioethics and health policy at Johns Hopkins and Georgetown Universities. Before entering academics, Fox practiced health law in a solo practice, representing patients around the United States in their dealings with third party payers and transplant list placements. Immediately following law school, she was an associate at Hogan & Hartson in Washington, DC. She received a JD (cum laude) and LLM from Georgetown University School of Law and a BA from Sarah Lawrence College.Fox's scholarship interests are focused on health law, primarily the relationships between justice, ethics, regulatory structures and markets. Her first article, published shortly after joining the faculty of USC, was about whether Medicare can consider cost when deciding whether to cover new medical technologies. This article was the subject of a conference at Yale University in December of 2006, held for the purpose of figuring out how Medicare can be changed so that cost considerations can be utilized. Her current scholarly work is in two areas. The first concerns the relationship between pharmaceutical and medical device manufacturers on one hand, and human research subjects on the other. The second is an ongoing examination of the choices we make regarding how to handle diseases that are introduced into humans through environmental vectors, for example wild migratory birds and avian flu.


Archive Events